Phesgo 600 mg/600 mg Leaflet: Uses, Side Effects & FAQs
Quick summary Phesgo is a combination injectable medicine containing pertuzumab and trastuzumab. It is used in adults with HER2-positive breast cancer in certain treatment settings. This page summarises the leaflet information in plain English,...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Phesgo is a combination injectable medicine containing pertuzumab and trastuzumab. It is used in adults with HER2-positive breast cancer in certain treatment settings. This page summarises the leaflet information in plain English, including common side effects, administration basics, and important safety points to discuss with a healthcare professional.
Medical disclaimer
This article is for general information only and does not replace the official patient leaflet or advice from a doctor, nurse, or pharmacist. Treatment decisions, monitoring, and any changes to therapy must be made by a qualified healthcare professional.
What is Phesgo?
Phesgo is an injectable cancer medicine that combines two monoclonal antibodies: pertuzumab and trastuzumab. It is used for some adults with HER2-positive breast cancer.
These medicines target the HER2 receptor, which is present in higher amounts on some breast cancer cells. By blocking this receptor, Phesgo helps interfere with signals that support cancer cell growth.
What is Phesgo used for?
According to the leaflet information, Phesgo is used in adults with HER2-positive breast cancer in different treatment settings, including:
- Before surgery to help shrink the tumour
- After surgery to help reduce the risk of the cancer coming back
- For metastatic disease, where the cancer has spread beyond the breast
The exact place of Phesgo in a treatment plan depends on the person’s diagnosis and the wider cancer treatment protocol.
How is Phesgo given?
Phesgo is given as a subcutaneous injection, meaning it is injected under the skin by a healthcare professional. It is not described here as a self-injection medicine.
The leaflet information notes that treatment usually starts with an initial dose, followed by maintenance doses, often given every three weeks. The healthcare team will decide the schedule and monitor the patient during treatment.
Possible side effects
Like all medicines, Phesgo can cause side effects. The leaflet information highlights the following common effects:
- Fatigue
- Nausea and vomiting
- Hair loss
- Injection site reactions
Serious side effects can also occur. The leaflet information mentions heart problems, including heart failure, and severe allergic reactions. Any unusual or worrying symptoms should be reported to a healthcare professional promptly.
People with a history of heart disease may need closer monitoring during treatment.
What should be checked before treatment?
Before starting Phesgo, the healthcare team may review several important points, including:
- Any history of heart disease
- Previous treatment with similar medicines
- Pregnancy or breastfeeding status
- Whether regular monitoring or tests are needed during treatment
Patients should always tell their healthcare team about other medicines, medical conditions, and any symptoms that develop during treatment.
How long does Phesgo stay in the body?
The leaflet information notes that Phesgo can remain in the body for some time after administration. A half-life of around 15 to 20 days is mentioned, which means the medicine may stay in the system for several weeks.
This is one reason why follow-up and monitoring may continue throughout treatment and afterwards, depending on the treatment plan.
What patients should verify with the leaflet or care team
If you are reading the official leaflet, it is helpful to confirm:
- Why Phesgo has been prescribed in your specific treatment plan
- How often injections are scheduled
- Which side effects need urgent medical attention
- What monitoring is planned, especially for heart function
- Whether any other cancer medicines are being used alongside Phesgo
Frequently asked questions
▸ What is PHESGO used for?
PHESGO is used in adults with HER2-positive breast cancer in certain treatment settings, including before surgery, after surgery, and for metastatic disease.
▸ How is PHESGO administered?
It is given as a subcutaneous injection by a healthcare professional. The leaflet information describes an initial dose followed by maintenance doses, often every three weeks.
▸ What are the most common side effects?
The leaflet information lists fatigue, nausea and vomiting, hair loss, and injection site reactions among the common side effects.
▸ Are there serious side effects to watch for?
Yes. The leaflet information mentions heart problems, including heart failure, and severe allergic reactions. Any concerning symptoms should be reported promptly.
▸ Do patients need monitoring during treatment?
Yes. The leaflet information indicates that regular monitoring may be needed, especially to check heart function and overall response to treatment.
▸ How long can someone stay on PHESGO?
The length of treatment varies depending on the person’s clinical situation and response. The healthcare team decides the treatment duration.
Safety reminder
If you have questions about side effects, monitoring, pregnancy, breastfeeding, or heart symptoms, speak with your oncology team or pharmacist and refer to the official leaflet. Seek urgent medical help for severe allergic symptoms or sudden worsening health concerns.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.